Paroxetine Tablet, Film Coated
Product Images NDC 68071-2835

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68071-2835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2835 9)

Paroxetine 20 mg film-coated tablets label by NuCare Pharmaceuticals, Inc. The label notes a package size of 90 tablets, with paroxetine hydrochloride USP equivalent to 20 mg of paroxetine per tablet. The tablets are described as capsule-shaped, beige to light brown, scored with '711' on one side and 'HH' on the other. The label includes storage instructions and regulatory warnings.*

FDA Label Image

Picture1 (Image 05)

Chemical structure of paroxetine hydrochloride hemihydrate, showing the molecular arrangement including a fluorophenyl group, a piperidine ring, and a lactone moiety, consistent with the active ingredient of Paroxetine 20 mg film-coated tablets by NuCare Pharmaceuticals, Inc.*

FDA Label Image

Figure (Image 06)

A pharmacokinetic (PK) fold change graph showing the effects of various interacting drugs on Cmax and AUC values. The chart compares fold changes and 90% confidence intervals for pimozide, desipramine, propranolol, digoxin, and phenytoin relative to a reference, plotted on a logarithmic scale from 0.1 to 10.0.*

FDA Label Image

Figure2 (Image 07)

A forest plot chart showing the fold change and 90% confidence intervals of pharmacokinetic parameters Cmax and AUC for various interacting drugs (Cimetidine, Phenobarbital, Phenytoin, Digoxin, Diazepam) relative to a reference. The x-axis represents change relative to reference, ranging from 0 to 2, with data points and error bars for each drug and parameter.*

FDA Label Image

Figure 3 (Image 08)

Pharmacokinetic fold change and 90% confidence interval plot showing Cmax, Cmin, and AUC values for paroxetine hydrochloride hemihydrate in populations with varying renal impairment (mild, moderate, severe), hepatic impairment, age groups (>65 years) with different doses, and gender (males). The horizontal axis represents change relative to reference values on a logarithmic scale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.